New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 23, 2012
10:32 EDTARMH, LGF, RY, BMC, XOM, HTWR, AZN, COF, STDOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: ARM Holdings (ARMH) upgraded to Neutral from Underweight at JPMorgan... AstraZeneca (AZN) upgraded to Equal Weight from Underweight at Barclays... BMC Software (BMC) upgraded to Positive from Neutral at Susquehanna... Banco Santander (STD) upgraded to Conviction Buy from Neutral at Goldman... Banco Santander upgraded to Overweight from Neutral at JPMorgan... HeartWare (HTWR) upgraded to Overweight from Equal Weight at Barclays... Royal Bank of Canada (RY) upgraded to Buy from Neutral at BofA/Merrill... Capital One (COF) upgraded to Overweight from Neutral at JPMorgan... Exxon Mobil (XOM) upgraded to Outperform from Market Perform at Raymond James... Lions Gate (LGF) upgraded to Above Average from Average at Caris.
News For ARMH;AZN;BMC;STD;HTWR;RY;COF;XOM;LGF From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 20, 2015
10:00 EDTLGFOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:44 EDTLGFLionsgate initiated with a Buy at Jefferies
Subscribe for More Information
May 19, 2015
16:45 EDTRYCity National reaches tentative settlement in shareholder dispute of RBC merger
Subscribe for More Information
15:05 EDTAZNArdelyx scheduled for end Phase 2 meeting with FDA scheduled in June
Subscribe for More Information
May 18, 2015
06:13 EDTAZNAstraZeneca to invest $285M in new biologics manufacturing facility in Sweden
AstraZeneca announced that it plans to invest approximately $285M in a new high-tech facility for manufacturing of biological medicines in Södertälje, Sweden. The new plant will be focused on filling and packaging of protein therapeutics. It is anticipated that the new facility will supply medicines for clinical trial programs of AstraZeneca and MedImmune, the company’s global biologics research and development arm, from the end of 2018, and will deliver finished products for commercial use once fully operational by 2019. Södertälje is currently home to AstraZeneca’s largest global tablets and capsules manufacturing facility and is also a launch platform site for the company, with specialist capabilities on-site that allow large-scale production of new medicines, working closely with the research and development organisation. By locating the new manufacturing plant in Södertälje, the company will combine its expertise in biologics with the well-established culture of operational excellence that exists within the Sweden Operations unit. The planned investment will, subject to relevant approvals by the local authorities, create between 150 and 250 highly skilled new roles at AstraZeneca by 2019. The new manufacturing facility in Sweden will support the progression of drug candidates across the main therapy areas and be aligned with investments being made in the current biologics manufacturing centers, such as the expansion in Frederick, Maryland, announced in November.
May 17, 2015
15:49 EDTAZNAstraZeneca reports Movantik shows 'similar' adverse event rate vs. placebo
Subscribe for More Information
May 15, 2015
10:55 EDTLGFJANA Partners gives quarterly update on stakes
Subscribe for More Information
09:31 EDTAZNAmerican Thoracic Society to hold a conference
ATS 2015 Conference is being held in Denver on May 15-20.
06:44 EDTXOMEnvironmentalists file lawsuit over oil train safety rules, NY Times says
Subscribe for More Information
06:05 EDTCOFCapital One reports April net charge-off rate 3.66% vs. 3.63% last month
Subscribe for More Information
May 14, 2015
09:22 EDTAZNLeerink pharma/biotech analysts hold an analyst/industry conference call
Subscribe for More Information
05:52 EDTAZNMizuho expects CAR T stocks to be volatile after ASCO abstract
Subscribe for More Information
May 13, 2015
17:24 EDTAZNAstraZeneca to update progress with immuno-oncology pipeline at ASCO
AstraZeneca and MedImmune, the company’s global biologics research and development arm, will demonstrate rapid progress with their combination-focused oncology pipeline at the American Society of Clinical Oncology, or ASCO, Annual Meeting, May 29-June 2. 61 scientific abstracts will be presented at the meeting, reinforcing the significant progress in immuno-oncology through combination therapies and innovative companion diagnostics.
10:07 EDTARMHHigh option volume stocks
Subscribe for More Information
07:10 EDTLGFB. Riley to hold a conference
Subscribe for More Information
May 12, 2015
14:13 EDTRYBove says it may be time to buy bank stocks
Subscribe for More Information
May 11, 2015
13:28 EDTXOMOPEC sees oil at around $76 a barrel in 2025, WSJ says
Subscribe for More Information
11:03 EDTLGFLionsgate, Google Play partner on 'The Mad Men Experience'
Subscribe for More Information
10:01 EDTXOMExxon Mobil announces Cold Lake project expansion begins production on schedule
Subscribe for More Information
May 10, 2015
17:35 EDTLGFDisney's 'Avengers: Age Of Ultron' leads U.S. weekend box office with $77.2M
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use